Ocrevus 9-Year Data [Observational Study]
How effective and safe is ocrevus when taken for many years? This video looks at data from a 9-year observational study, a follow up of the OPERA I and OPERA II randomized trials. We review efficacy in preventing disability and relapses and the risk of infections and cancer. Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: https://pmc.ncbi.nlm.nih.gov/articles... Comment or ask questions below! I would be happy to answer! Subscribe on YouTube for more videos every Wednesday! Make video requests in the comments section! Check out my book “Resilience in the Face of Multiple Sclerosis” FREE on Amazon: https://amazon.com/dp/B07WP7H5LK It's about 5 people with MS who live incredible lives, the science and psychology of resilience, mindfulness, and ho’oponopono. Paperback priced to generate $0 royalty. Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. He is a partner in the Southern California Permanente Medical Group and practices in Downey, California (South Los Angeles). He has several publications on MS epidemiology and has participated in clinical trials for MS therapeutics. You can follow him on twitter @Brandon_Beaber where he regularly posts about MS news and research. Follow me on twitter: / brandon_beaber Music: INNER GRACE - Copyright 2018 Wilton Vought Source: Really Really Free Music Link: • Video T he video material by Dr. Brandon Beaber is general educational material on health conditions and is not intended to be used by viewers to diagnose or treat any individual's medical condition. Specifically, this material is not a substitute for individualized diagnostic and treatment advice by a qualified medical/health practitioner, licensed in your jurisdiction, who has access to the relevant information available from diagnostic testing, medical interviews, and a physical examination. To the extent that Dr. Beaber endorses any lifestyle change, behavioral intervention, or supplements, the viewer should consult with a qualified healthcare professional to determine the safety and efficacy of the intervention in light of their individualized information.

NSAIDs Explained | Why Is There So Many Kinds?

CNS Infections | Clinical Medicine

Multiple Sclerosis Progression and Pathophysiology "Chalk Talk" by a Neurologist

Best Multiple Sclerosis Medicine for Preventing Disability

I Stopped Using Nattokinase. Here’s Why.

HSCT vs Tysabri , Ocrevus, and Gilenya in Observational Study Explained by Neurologist

How Immunosuppressive Are Multiple Sclerosis Drugs? Explained by Neurologist

Dr. Aaron Boster is Right About This

This New Histamine Treatment Helped 89% of Patients

BTK Inhibitors in Multiple Sclerosis Treatment

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions

More Vitamin D in Early CLL Improves Treatment-Free Survival

NEW form of administration - what's the difference? Ocrevus - intravenous or subcutaneous? | Oh, ...

Safe Tapering Practices for Anti-Depressants with Dr. Mark Horowitz

Multiple Sclerosis Starts Years Before Symptom Onset

What You Need to Know about Risk, Safety, and Tolerability of MS DMTs

Fenebrutinib Deaths

Medical detective

Eli Lilly CEO: How GLP-1s Will Reshape America

